NCT03438240View on ClinicalTrials.gov

Dexmedetomidine Versus Fentanyl Plus Bupivacaine for Epidural Analgesia With General Anesthesia for Lumbar Disc Operations

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

July 5, 2018

Study Completion Date

August 15, 2018

Conditions
Anesthesia
Interventions
DRUG

Bupivacaine

patients will receive combined general anesthesia / epidural analgesia with 15 ml bupivacaine 0.20%

DRUG

Fentanyl

Plus 50 µg fentanyl

DRUG

Dexmedetomidine

Plus 50 µg dexmedetomidine

Trial Locations (1)

11591

Ain Shams University hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03438240 - Dexmedetomidine Versus Fentanyl Plus Bupivacaine for Epidural Analgesia With General Anesthesia for Lumbar Disc Operations | Biotech Hunter | Biotech Hunter